For protocol design, anchor the dosing range you select to a specific cited study matching your model
Pekala J, Patkowska-Sokoa B, Bodkowski R, Jamroz D, Nowakowski P, Lochyski S, Librowski T
The FDA will determine whether to issue a proposed rule that would add BPC-157 to the 503A Bulks List
10.1053/j.gastro.2011.02.018 8 FangH.WangX.LanX.JiangD
Recalls & Warnings November 06, 2014 Seller of Cholesterol, Arthritis Supplements and More Warned for Drug Claims On October 17, 2014, the FDA issued a warning letter to Vitamins Direct (USA) and Golden Pride, Inc., which distribute Flexezy and Physician's Signature brands of dietary supplements, following a facility inspection which found statements made about certain supplements to be drug claims